VistaPharm LLC recalls Sucralfate Oral Suspension 1g per 10mL, FOR ORAL ADMINISTRATION ONLY (414 mL bottle), Rx Only, Manufactured and Distrib…
- Recall date
- August 30, 2023
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-1149-2023
- FDA classification
- Class II
- Brand / firm
- VistaPharm LLC
- Sold / distributed
- Distributed nationwide to 68 consignees in the U.S.
Why it was recalled
Superpotent/Subpotent single ingredient Drug: Out of Specification Assay results
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Sucralfate Oral Suspension 1g per 10mL, FOR ORAL ADMINISTRATION ONLY (414 mL bottle), Rx Only, Manufactured and Distributed by: VistaPharm, Inc. Largo, FL 33771, NDC 66689-305-16
Get recall alerts
Free email alert whenever VistaPharm LLC has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: VistaPharm LLC